$28.40
1.18% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
IE00BGH1M568
Symbol
PRGO

Perrigo Company Stock price

$28.40
+3.31 13.19% 1M
+0.52 1.87% 6M
-3.78 11.75% YTD
-2.35 7.64% 1Y
-10.43 26.86% 3Y
-21.65 43.26% 5Y
-128.07 81.85% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.33 1.18%
ISIN
IE00BGH1M568
Symbol
PRGO
Sector
Industry

Key metrics

Market capitalization $3.87b
Enterprise Value $7.35b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 48.48
EV/Sales (TTM) EV/Sales 1.67
P/S ratio (TTM) P/S ratio 0.88
P/B ratio (TTM) P/B ratio 0.85
Dividend yield 3.89%
Last dividend (FY24) $1.10
Revenue growth (TTM) Revenue growth -5.59%
Revenue (TTM) Revenue $4.39b
EBIT (operating result TTM) EBIT $286.60m
Free Cash Flow (TTM) Free Cash Flow $151.70m
Cash position $1.46b
EPS (TTM) EPS $-1.11
P/E forward negative
P/S forward 0.87
EV/Sales forward 1.66
Short interest 4.09%
Show more

Is Perrigo Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Perrigo Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Perrigo Company forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Perrigo Company forecast:

Buy
86%
Hold
14%

Financial data from Perrigo Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
4,393 4,393
6% 6%
100%
- Direct Costs 2,808 2,808
7% 7%
64%
1,585 1,585
3% 3%
36%
- Selling and Administrative Expenses 853 853
6% 6%
19%
- Research and Development Expense 114 114
9% 9%
3%
618 618
2% 2%
14%
- Depreciation and Amortization 332 332
11% 11%
8%
EBIT (Operating Income) EBIT 287 287
21% 21%
7%
Net Profit -152 -152
19,038% 19,038%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Perrigo Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Perrigo Company Stock News

Positive
Seeking Alpha
7 days ago
Perrigo's long-term growth is driven by strategic initiatives like Project Energize, aiming for $140-$170 million in annualized savings by 2026. The company's reinvestments in leadership and IT, adding 200 years of consumer experience, are crucial for sustainable growth. Perrigo's supply chain reinvention program has already achieved $72 million in gross savings, enhancing cash flow and operati...
Neutral
Seeking Alpha
20 days ago
Perrigo Company plc (NYSE:PRGO ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Keith Devas - Jefferies Korinne Wolfmeyer - Piper Sandler Dan...
Neutral
PRNewsWire
20 days ago
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales Growth of +3% Compared to the Prior Year Quarter, +58% Sequentially Reaffirms Fiscal 2024...
More Perrigo Company News

Company Profile

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Self-Care International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Head office United States
CEO Patrick Lockwood-Taylor
Employees 9,140
Founded 1887
Website www.perrigo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today